Olanzapine increases glucogenesis by multiple pathways in brain and muscle.
Fatemi
S H
SH
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects; D005625:Frontal Lobe / Q000187:drug effects* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D005943:Gluconeogenesis / Q000187:drug effects; D005947:Glucose / Q000096:biosynthesis* / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D018485:Muscle Fibers, Skeletal / Q000187:drug effects*; D000077152:Olanzapine; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects
D014150:Antipsychotic Agents; D007328:Insulin; D001569:Benzodiazepines; D006003:Glycogen; D005947:Glucose; D000077152:Olanzapine